Petros Pharmaceuticals, Inc.
Returns on Capital
| Period | ROE | ROI | ROA |
|---|---|---|---|
| Mar 2020 | -314.2% | -314.2% | — |
| Jun 2020 | 150.6% | 150.6% | — |
| Sep 2020 | 46.3% | 46.3% | — |
| Mar 2021 | 14.4% | 14.4% | 4.5% |
| Jun 2021 | -10.8% | -10.8% | -3.7% |
| Sep 2021 | -9.5% | -9.5% | -3.3% |
| Mar 2022 | -0.5% | -0.5% | -0.3% |
| Jun 2022 | -5.3% | -5.3% | -3.5% |
| Sep 2022 | -66.8% | -66.8% | -36.7% |
| Mar 2023 | -9.0% | -9.0% | -4.5% |
| Jun 2023 | -19.7% | -19.7% | -8.9% |
| Sep 2023 | -65.6% | -65.6% | -11.7% |
| Mar 2024 | -22.1% | -22.1% | -7.1% |
| Jun 2024 | -8.2% | -8.2% | -2.6% |
| Sep 2024 | -71.3% | -71.3% | -10.7% |
| Mar 2025 | 23.6% | 23.6% | -12.8% |
| Jun 2025 | 122.2% | 122.2% | 73.4% |
| Sep 2025 | -27.4% | -27.4% | -15.0% |
| Mar 2026 | -55.7% | -55.7% | -22.5% |
| Jun 2026 | -136.3% | -136.3% | -27.0% |